Bunnage Mark E.
EVP, Chief Scientific Officer at VRTX
- Sold, on record
- $3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 15, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- VRTXVERTEX PHARMACEUTICALS INC / MAEVP, Chief Scientific Officer
Sales by reason
4
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale VRTXRoutineFeb 11 2026
Sold 2,021 shares at $460.43 ($931k)
Bunnage Mark E., EVP, Chief Scientific Officer
10b5-1 planSold 13.5% of holdings ($6.9M position)12,914 shares leftFirst sale on recordFiling
- 2 Form 4 sale VRTXRoutineFeb 18 +7 days
Sold 3,619 shares at $484.31 ($1.8M)
Bunnage Mark E., EVP, Chief Scientific Officer
10b5-1 planSold 29.9% of holdings ($5.9M position)8,486 shares leftFiling
- 3 Form 4 sale VRTXRoutineFeb 25 +7 days
Sold 620 shares at $486.35 ($302k)
Bunnage Mark E., EVP, Chief Scientific Officer
10b5-1 planSold 7.8% of holdings ($3.8M position)7,284 shares leftFiling
- 4 Form 4 sale VRTXRoutineMay 15 +79 days
Sold 33 shares at $453.45 ($15k)
Bunnage Mark E., EVP, Chief Scientific Officer
10b5-1 planSold 0.5% of holdings ($3.3M position)7,284 shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | VRTX | EVP, Chief Scientific Officer | Form 4 sale | 33 | $15k | 0.5% | Routine | SEC |
| Feb 25, 2026 | VRTX | EVP, Chief Scientific Officer | Form 4 sale | 620 | $302k | 7.8% | Routine | SEC |
| Feb 18, 2026 | VRTX | EVP, Chief Scientific Officer | Form 4 sale | 3,619 | $1.8M | 29.9% | Routine | SEC |
| Feb 11, 2026 | VRTX | EVP, Chief Scientific Officer | Form 4 sale | 2,021 | $931k | 13.5% | Routine | SEC |